首页 | 本学科首页   官方微博 | 高级检索  
     


Integration of PET/MR Hybrid Imaging into Radiation Therapy Treatment
Affiliation:1. Department of Radiation Oncology, University of North Carolina at Chapel Hill, 101 Manning Drive, Chapel Hill, NC 27599, USA;2. Department of Radiology, University of North Carolina at Chapel Hill, 101 Manning Drive, Chapel Hill, NC 27599, USA;1. Department of Clinical Molecular Biology, Medical University of Bialystok, Bialystok, Poland;2. Center of Clinical Research, Medical University of Bialystok, Bialystok, Poland;3. Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, Bialystok, Poland;4. Department of Medical Pathomorphology, Medical University of Bialystok, Bialystok, Poland;5. Laboratory of Molecular Imaging and Technology Development, Medical University of Bialystok, Bialystok, Poland;6. Department of Thoracic Surgery, Medical University of Bialystok, Bialystok, Poland;7. Department of Oncology, Poznan University of Medical Sciences, Poznan, Poland;8. Department of Thoracic Surgery, Poznan University of Medical Sciences, Poznan, Poland;9. Center of Bioinformatics and Data Analysis, Medical University of Bialystok, Bialystok, Poland;10. Institute of Animal Reproduction and Food Research of Polish Academy of Sciences, Olsztyn, Poland;11. Department of Gynecologic Oncology, Provincial Specialist Hospital in Olsztyn, Olsztyn, Poland;12. Second Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Bialystok, Poland;13. Department of Oncology, Medical University of Bialystok, Bialystok, Poland;14. Department of Neurosurgery, Medical University of Bialystok, Bialystok, Poland;15. Second Department of General and Gastroenterological Surgery, Medical University of Bialystok, Bialystok, Poland;p. Department of Gynecology and Gynecologic Oncology, Medical University of Bialystok, Bialystok, Poland;q. Chair of Clinical Pathomorphology, Poznan University of Medical Sciences, Poznan, Poland;r. First Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Bialystok, Poland;s. First Department of Lung Diseases and Chemotherapy of Respiratory Neoplasms, University Teaching Hospital, Bialystok, Poland;t. Department of Public Health, Medical University of Bialystok, Bialystok, Poland;u. Department of Neurodegeneration Diagnostics, Medical University of Bialystok, Bialystok, Poland;v. Second Department of Nephrology and Hypertension with Dialysis Unit, Medical University of Bialystok, Bialystok, Poland;w. Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany;x. Department of Experimental Surgery − Cancer Metastasis, Medical Faculty Mannheim, Ruprecht Karls University of Heidelberg and Center for Biomedicine and Medical Technology Mannheim (CBTM), Mannheim, Germany;y. Indivumed GmbH, Falkenreid 88, Hamburg, Germany;1. LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France;2. Nuclear medicine department, CHU Milétrie, Poitiers, France;1. Département de physique, de génie physique et d''optique et Centre de recherche sur le cancer, Université Laval, Québec, Canada;2. Département de radio-oncologie et CRCHU de Québec, CHU de Québec, Québec, Canada;3. Department of Radiation Oncology (MAASTRO), GROW—School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands;4. Medical Physics Unit, McGill University Health Centre and Department of Oncology, McGill University, Montréal, Québec, Canada;1. Abdominal Imaging Section and Nuclear Medicine Department, Imaging Institute and Taussig Cancer Institute, Cleveland Clinic Main Campus, Mail Code JB3, 9500 Euclid Avenue, Cleveland, OH 44195, USA;2. Nuclear Medicine, Department of Radiology, 2006 Old Clinic, CB# 7510, Chapel Hill, NC 27599, USA
Abstract:
Keywords:Hybrid PET/MR imaging  Radiation therapy  PET tracers  Tumor response  Normal tissue toxicity  Tumor heterogeneity  MRI-based treatment planning
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号